These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Peripheral arterial occlusive disease--acute intervention and after-care]. Stenzinger W, van de Loo J. Z Kardiol; 1993; 82 Suppl 5():71-7. PubMed ID: 8154165 [Abstract] [Full Text] [Related]
4. [Overview of the most frequent clinical manifestations of peripheral arterial occlusive disease in the elderly, its diagnosis and stage-related therapy]. Ebert D. Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):525-31. PubMed ID: 9441027 [Abstract] [Full Text] [Related]
5. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease]. Scheffler A, Rieger H. Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827 [Abstract] [Full Text] [Related]
6. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease]. Aligne C, Mosnier M, Mistretta F, Larguier JS. J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634 [Abstract] [Full Text] [Related]
14. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Maksimović ZV. Srp Arh Celok Lek; 1999 Jul; 127(7-8):249-53. PubMed ID: 10624398 [Abstract] [Full Text] [Related]
15. [Which therapeutic measures ensure good long-term results in arterial occlusive disease?]. Schoop W. Arzneimittelforschung; 1990 Mar; 40(3A):379-81. PubMed ID: 2185769 [Abstract] [Full Text] [Related]
18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [Abstract] [Full Text] [Related]